Zen Technologies (ZENTEC)
Fast GrowerFairStock Score: 38/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,857.2 |
| Market Cap | ₹16,704.05 Cr |
| P/E Ratio | 92.58 |
| ROCE | 37.22% |
| ROE | 15.46% |
| Dividend Yield | 0.05% |
| Profit Growth | -21.3% |
| Debt/Equity | 0.01 |
| Sales Growth | -8% |
| Free Cash Flow | ₹-969 Cr |
| Promoter Holding | 48.51% |
| 52-Week Range | ₹1,223 — ₹2,041.9 |
| Sector | Aerospace & Defense |
| Book Value | ₹199.84 |
Strengths
- Five-year revenue CAGR of 77.68% with latest sales growth of 28.84% and profit growth of 44.45%.
- Near debt-free balance sheet: D/E of 0.01 and Altman Z-Score of 5.35 indicate strong financial stability.
- High capital efficiency with ROCE of 37.22%, suggesting a competitive edge in defense niche.
- Promoter holding of 48.51% aligns management interests with minority shareholders.
- Piotroski F-Score of 7/9 reflects solid fundamentals; latest quarter net margin is roughly 31.5%.
Concerns
- Valuation is stretched: P/E of 46.81, P/B of 9.14, PEG of 2.43, and margin of safety of -270.08% versus Graham Number of ₹367.46.
- Free cash flow is deeply negative at -₹969 Cr despite reported profits, pointing to weak cash conversion.
- Negative EV/EBITDA of -214.62 makes earnings-based valuation unreliable and raises questions about capital structure or earnings quality.
- Dividend yield of just 0.15% offers negligible income support, while ROE of 15.46% is moderate for such a high book multiple.
AI Analysis
Let's look at Zen Technologies the way Graham would: a fast-growing defense play, but the price demands far more than the business currently delivers. A 77.68% five-year revenue CAGR and 28.84% latest sales growth are impressive; profit growth of 44.45% and a latest-quarter net margin of about 31.5% show operating leverage. The balance sheet has almost no debt, with D/E of 0.01, ROCE of 37.22% suggests a capital-efficient franchise, and an Altman Z-Score of 5.35 indicates no near-term solvency risk. Promoters hold 48.51%, which ties their interests with ours. The Piotroski F-Score of 7/9 also confirms broad fundamental health. So the business quality is real. But I cannot ignore valuation. At ₹1,721.20, the P/E is 46.81, P/B is 9.14, and the Graham Number is ₹367.46, meaning the market price offers a margin of safety of -270.08%. Even accounting for growth, the PEG is 2.43; the market has already priced in years of outstanding performance. A 15.46% ROE does not justify a 9.14 times book multiple. More troubling, free cash flow is -₹969 Cr despite a reported net profit of ₹56 Cr in the latest quarter. Profit without cash is a warning light. The negative EV/EBITDA of -214.62 makes conventional earnings valuation unreliable, and the dividend yield of 0.15% offers no income support. This is a good business, but a good business is not necessarily a good investment at any price. At today's quote, there is no margin of safety. I would wait patiently for a far more reasonable entry point.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer